BATS BZX Real-Time Price
As of 2:57pm ET
| -0.31 / -1.83%|
The 3 analysts offering 12-month price forecasts for Edge Therapeutics Inc have a median target of 17.00, with a high estimate of 21.00 and a low estimate of 17.00. The median estimate represents a +2.41% increase from the last price of 16.60.
The current consensus among 3 polled investment analysts is to Buy stock in Edge Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.